Life-science briefing: Wednesday, April 9, 2008
TODAY’S HEADLINES:
Stemline Therapeutics, cancer stem-cell startup, gets $13M (release)
Eye-disease biotech Potentia Pharma raises $12M (release)
Sample-prep toolmaker Arcxis aims for $8M to $10M (VentureWire)
Synvascular names Drew Hoffman as CEO (VentureWire)
ArtusLabs gets $2.6M for life-science software and services (release)
Cancer-drug maker Inotek loses CEO, Genentech partnership (release)
GTESS, health-plan IT startup, names James Bradley CEO (release)
Antibiotic developer Tetraphase Pharma names Guy MacDonald CEO (release)
Stemline Therapeutics, cancer stem-cell startup, gets $13M – New York-based Stemline Therapeutics, a biotech focused on new… Continue Reading
Life sciences briefing: Tuesday, Oct. 23, 2007
Featured companies: Apex Radiology, Arcxis Biotechnologies, EKR Therapeutics, Franklin & Seidelmann, Michelson Diagnostics, SensiGen, Vascular Closure Systems
UPDATED: Expanded items on Arcxis, Vascular Closure and Archemix.
Arcxis pulls in $2M for DNA tools — Arcxis Biotechnologies, a Pleasanton, Calif., biotech tool maker focused on analysis of DNA and proteins in biological samples, raised $2 million in a follow-on to its first funding round, VentureWire reports (subscription required). Investors included Kaiser Permanente Ventures and Claremont Creek Ventures.
Arcxis released its first… Continue Reading